Retinal gene delivery by rAAV and DNA electroporation
Department of Ophthalmology; Gene Therapy Center; Department of Microbiology and Physiological Systems
Dependovirus; Genetic Vectors; Genetic Therapy; Gene Transfer Techniques; Eye
Genetics and Genomics | Microbiology | Molecular Genetics | Ophthalmology
Ocular gene therapy is a fast-growing area of research. The eye is an ideal organ for gene therapy since it is immune privileged and easily accessible, and direct viral delivery results primarily in local infection. Because the eye is not a vital organ, mutations in eye-specific genes tend to be more common. To date, over 40 eye-specific genes have been identified harboring mutations that lead to blindness. Gene therapy with recombinant adeno-associated virus (rAAV) holds the promise to treat patients with such mutations. However, proof-of-concept and safety evaluation for gene therapy remains to be established for most of these diseases. This unit describes the in vivo delivery of genes to the mouse eye by rAAV-mediated gene transfer and plasmid DNA electroporation. Advantages and limitations of these methods are discussed, and detailed protocols for gene delivery, required materials, and subsequent tissue processing methods are described.
Rights and Permissions
Citation: Curr Protoc Microbiol. 2013 Feb;Chapter 14:Unit 14D.4. doi: 10.1002/9780471729259.mc14d04s28. Link to article on publisher's site
Current protocols in microbiology
Venkatesh, Aditya; Ma, Shan; Langellotto, Fernanda; Gao, Guangping; and Punzo, Claudio, "Retinal gene delivery by rAAV and DNA electroporation" (2013). University of Massachusetts Medical School Faculty Publications. 190.